US Broker Ratings

Halozyme Therapeutics, Inc. (HALO): Investor Outlook and Growth Potential with a Strong Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has carved a niche in the biotechnology sector with its innovative enzyme-based therapies, positioning itself as a formidable player in the healthcare landscape. The company’s..

Waystar Holding Corp. (WAY) Stock Analysis: 45.66% Upside Potential in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology sector, is capturing significant attention from investors with its robust potential upside of 45.66%. Founded in 2017 and..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with a 56.89% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising clinical-stage cancer therapies. Despite operating at a financial loss, the..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 29.48% Potential Upside for Biotech Investors

Bio-Techne Corp (TECH), a significant player in the biotechnology industry, presents a compelling investment opportunity for those eyeing the healthcare sector. With a market capitalization of $7.9 billion, Bio-Techne operates..

Avantor, Inc. (AVTR) Stock Analysis: A Closer Look at Its 22.76% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.84 billion, Avantor is a substantial..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Biotechnology Innovator with a 47.89% Potential Upside

Roivant Sciences Ltd. (ROIV), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and development. With a market capitalization..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Powerhouse with a 23% Upside

Investors looking to navigate the intricate world of healthcare stocks might find Danaher Corporation (NYSE: DHR) particularly enticing. With its robust presence in the diagnostics and research industry, Danaher stands..

Veeva Systems Inc. (VEEV) Stock Analysis: Uncovering Growth Potential with a 16.7% Revenue Surge

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, presents a compelling case for investors with its robust revenue growth and innovative product..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with an 18.33% Upside

Teleflex Incorporated (NYSE: TFX) represents a dynamic player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in Wayne, Pennsylvania, the company has carved a niche..

Centene Corporation (CNC) Stock Analysis: Exploring a 35% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC) is a prominent player in the healthcare sector, catering to under-insured and uninsured families across the United States. Operating through diverse segments such as Medicaid, Medicare,..

Teva Pharmaceutical Industries (TEVA): Analyst Consensus Projects 43% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, has captured investor attention with its strong position in the specialty and generic drug manufacturing space. Based in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 51.63% Potential Upside Amid Robust Revenue Growth

In the dynamic world of biotechnology, TG Therapeutics, Inc. (NASDAQ: TGTX) stands out with its promising outlook and innovative approach to treating B-cell mediated diseases. With a market capitalization of..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 25.92% Upside with Strategic Innovation in Biotech

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, with a robust market capitalization of $59.67 billion. The company’s strategic focus on innovative treatments across..

AptarGroup, Inc. (ATR) Stock Analysis: 21.85% Potential Upside Beckons Investors

Investors eyeing AptarGroup, Inc. (NYSE: ATR) may find its current positioning intriguing, especially given the potential upside of 21.85% forecasted by analysts. With a market capitalization of $9.27 billion, AptarGroup..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.54% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is capturing investor attention with its solid market performance and a potential upside of 9.54%. As a key player..

Natera, Inc. (NTRA) Stock Analysis: Exploring a 30% Upside Potential Amid Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has caught the attention of investors with its significant growth trajectory and..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 29% Upside with Robust Revenue Growth

Molina Healthcare Inc (NYSE: MOH), with a market capitalization of $8.5 billion, is a prominent player in the U.S. healthcare sector, specifically within the healthcare plans industry. Founded in 1980..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 14.31% Potential Upside in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, operates as a leading plasma therapeutic company with a robust international presence. Headquartered in Barcelona, Spain, Grifols has established itself..

McKesson Corporation (MCK) Stock Analysis: A 17% Upside Potential in the Healthcare Giant

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is garnering significant attention as investors weigh its robust market position against a backdrop of compelling growth metrics and analyst..

Ascendis Pharma A/S (ASND) Stock Analysis: A 31% Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector should take a closer look at Ascendis Pharma A/S (NASDAQ: ASND), a dynamic company headquartered in Hellerup, Denmark. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds